Filing Details
- Accession Number:
- 0001179110-17-012842
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-02 16:24:26
- Reporting Period:
- 2017-09-28
- Accepted Time:
- 2017-10-02 16:24:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1235010 | Momenta Pharmaceuticals Inc | MNTA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1229450 | A Craig Wheeler | C/O Momenta Pharmaceuticals, Inc. 675 West Kendall Street Cambridge MA 02142 | President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-09-28 | 25,667 | $7.41 | 286,121 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-09-28 | 25,667 | $19.03 | 260,454 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-28 | 10,000 | $19.02 | 282,638 | No | 4 | S | Indirect | Craig Wheeler Revocable Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Indirect | Craig Wheeler Revocable Trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2017-09-28 | 25,667 | $0.00 | 25,667 | $7.41 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
25,666 | 2008-05-22 | 2018-02-22 | No | 4 | M | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2016.
- This transaction was executed in multiple trades at prices ranging from $19.00 to $19.125. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $19.00 to $19.125. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.